These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2819950)

  • 1. The dopamine and serotonin systems during aging in human and rodent brain. A brief review.
    Morgan DG
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):153-7. PubMed ID: 2819950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease.
    Morgan DG; May PC; Finch CE
    J Am Geriatr Soc; 1987 Apr; 35(4):334-45. PubMed ID: 3549845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter receptors in the central nervous system and aging: pharmacological aspect (review).
    Burchinsky SG
    Exp Gerontol; 1984; 19(4):227-39. PubMed ID: 6094228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb].
    Zimin IA; Abaimov DA; Budygin EA; Zolotarev IuA; Kovalev GI
    Eksp Klin Farmakol; 2010 Feb; 73(2):2-5. PubMed ID: 20369592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.
    Delion S; Chalon S; Guilloteau D; Besnard JC; Durand G
    J Neurochem; 1996 Apr; 66(4):1582-91. PubMed ID: 8627314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.
    Kilpatrick GJ; Hagan RM; Gale JD
    Behav Brain Res; 1996; 73(1-2):11-3. PubMed ID: 8788470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoaminergic regulation of brain somatostatin metabolism in rats.
    Maeda K; Kakigi T; Kawata E; Kaneda H
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):109-10. PubMed ID: 1684392
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
    Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
    Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
    Carrey N; Kutcher S
    J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
    [No Abstract]   [Full Text] [Related]  

  • 13. From arousal to cognition: the integrative position of the prefrontal cortex.
    Robbins TW
    Prog Brain Res; 2000; 126():469-83. PubMed ID: 11105663
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine and serotonin receptors mediating contractions of the snail, Helix pomatia, salivary duct.
    Kiss T; Hiripi L; Papp N; Elekes K
    Neuroscience; 2003; 116(3):775-90. PubMed ID: 12573719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.
    Hermann H; Marsicano G; Lutz B
    Neuroscience; 2002; 109(3):451-60. PubMed ID: 11823058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed model for self-injurious behavior.
    Pies R
    Am J Psychiatry; 1992 Mar; 149(3):420. PubMed ID: 1536298
    [No Abstract]   [Full Text] [Related]  

  • 19. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of drugs and electroshock treatment on cerebral monoaminergic systems.
    Barkai AI
    Ann N Y Acad Sci; 1986; 462():147-62. PubMed ID: 2423001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.